SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-041230
Filing Date
2024-09-16
Accepted
2024-09-16 21:00:47
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3116
  Complete submission text file 0001140361-24-041230.txt   4570
Mailing Address C/O VION PHARMACEUTICALS, INC. 4 SCIENCE PARK NEW HAVEN CT 06511
Business Address
Fitzgerald Meghan (Reporting) CIK: 0001349297 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 241302355

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)